You just read:

Ventana receives FDA approval for the first fully automated IHC companion diagnostic to identify lung cancer patients eligible for XALKORI® (crizotinib)

News provided by

Ventana Medical Systems, Inc.

15 Jun, 2015, 12:00 BST